top of page


Inside Genève Ophtalmologie: How VisionOne™ transforms glaucoma diagnostics and clinic efficiency
A leading Swiss clinic embracing modern glaucoma care Located in the heart of Geneva, Genève Ophtalmologie is a modern, state-of-the-art private eye care center that has quickly established itself as a reference since opening in 2023. The clinic is designed around a patient-centered model and brings together a highly specialized team of ophthalmologists, orthoptists, and diagnostic technicians to provide comprehensive, cutting-edge care. Its areas of expertise include glaucom
Jan 12


Case study: Bringing next-generation visual field testing to clinics across Germany
In Germany’s rapidly evolving ophthalmic landscape , innovation is essential to meet growing clinical demands and the needs of an aging population. With more than 8,000 practicing ophthalmologists and a strong tradition of excellence in diagnostics and research, the German market has long been at the forefront of adopting technologies that improve both efficiency and patient experience. At the heart of this transformation stands Alpha Eyes GmbH , a German and Austrian-based l
Oct 28, 2025


What US eye care professionals want most from the next generation of perimetry
Introduction The landscape of glaucoma care in the United States is shifting rapidly. With the aging population growing and glaucoma cases on the rise, eye care professionals are under increasing pressure to deliver faster, more accurate, and more accessible diagnostics. Perimetry, the gold standard for detecting and monitoring glaucoma, is central to this challenge. However, traditional visual field testing (VFT) systems often slow down clinical workflows and create barriers
Sep 26, 2025


How AI is transforming glaucoma care: from research to real-world application
Introduction Artificial intelligence is not the future of ophthalmology, it’s already reshaping it. Glaucoma, the leading cause of irreversible blindness, affects more than 80 million people worldwide. Among them, primary open-angle glaucoma (POAG) alone impacts 57.5 million individuals, with prevalence strongly correlated with age. In Europe, over 7.8 million people were affected in 2020, and in Switzerland, it's estimated that up to 100,000 people live with glaucoma, often
Sep 12, 2025


How VisionOne™ is changing the future of glaucoma diagnostics
VisionOne™ was built to change that. Created by PeriVision in partnership with Switzerland’s largest eye clinic, the Inselspital, VisionOne™ is a VR-based visual field testing platform designed for speed, accessibility, and clinical precision. It brings together patented AI, portable user-friendly hardware, and intuitive software to reimagine how glaucoma is detected and monitored.
Aug 13, 2025
bottom of page

